First case report of polymyxin B-induced drug fever in a patient with carbapenem-resistant Acinetobacter baumannii pneumonia
Frontiers in Pharmacology · 16.06.2026 · 17
DOI: 10.3389/fphar.2026.1812802 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 16.06.2026. Verfasst von Ying Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Medical Science, Chongqing Three Gorges Medical College, Chongqing, China. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The escalating global prevalence of carbapenem-resistant Gram-negative bacteria has significantly constrained therapeutic options, leading to the revived use of polymyxins. However, this resurgence has been paralleled by an increase in reports of associated adverse effects. No case of drug fever induced by polymyxin B (PMB) has been reported in the literature to date. We report the first case of drug fever (≥39 °C) induced by intravenous PMB in a patient with severe pneumonia caused by carbapenem-resistant Acinetobacter baumannii , accompanied by tachypnea following concomitant nebulized PMB administration. Upon intervention by the clinical pharmacist, which involved discontinuation of PMB and adjustment of the anti-infective regimen, the patient’s fever resolved promptly and the infection was successfully controlled. This case highlights a severe and previously unreported adverse drug reaction to PMB, underscoring the necessity for vigilant monitoring and proactive antimicrobial stewardship in managing infections.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Basic Medical Science, Chongqing Three Gorges Medical College, Chongqing, China.
- Department of Pharmacy, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, China.
- Intensive Care Unit, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, Chongqing, China.
Zitieren
APA
Liu, Y., Liu, X., Zou, L., Wang, C., Xu, X. X., Min, L., & Guo, P. (2026). First case report of polymyxin B-induced drug fever in a patient with carbapenem-resistant Acinetobacter baumannii pneumonia. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1812802
Vancouver
Liu Y, Liu X, Zou L, Wang C, Xu XX, Min L, et al. First case report of polymyxin B-induced drug fever in a patient with carbapenem-resistant Acinetobacter baumannii pneumonia. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1812802
BibTeX
@article{Liu2026,
author = {Liu, Ying and Liu, Xiang and Zou, Li and Wang, Chen and Xu, Xing-Xing and Min, Li and Guo, Pei},
title = {First case report of polymyxin B-induced drug fever in a patient with carbapenem-resistant Acinetobacter baumannii pneumonia},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1812802}
}
EUVIMED